ADA2 p.Gly25Ser
c.73G>A · rs373732727 · VCV2079157
Computational evidence
| Protein change | ||
| AlphaMissense | 0.079 | likely benign |
|---|---|---|
| REVEL | 0.055 | moderately benign-leaning |
| SaProt | LLR -4.97 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | Δ0.43 | acceptor gain · deltas |
| Pangolin | Δ0.37 | gain · loss 0.00 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 0.14 | GERP -3.5 |
| Overall | ||
| CADD | 3.871 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00549% | 18,216 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,241 |
| African / African-American | 0.00267% | 37,432 |
| East Asian | 0.00223% | 44,892 |
| Admixed American | 0.00167% | 59,962 |
| European (non-Finnish) | 0.000763% | 131,116 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADA2
- Protein
- p.Gly25Ser
- Coding
- c.73G>A
- MANE Select
- NM_001166105 · reported on NM_001282225
- dbSNP
- rs373732727
- Type
- single nucleotide variant
- Location
- chr22:17209605 (GRCh38)
- Structure
- AlphaFold pLDDT 85.04 · 1 PDB
Disease context
deficiency of adenosine deaminase 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Deficiency of adenosine deaminase 2 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- ADA2 p.Gly25Cys Uncertain significance ★★ ⚠ same residue
- ADA2 p.Gly25= Likely benign ★ same residue
- ADA2 p.Gly25fs Likely pathogenic ★ same residue
- TADA2A p.Met25Val Uncertain significance ★ ⚠ same residue
- ADA2 c.754-2A>G Likely pathogenic ★★ same condition
- ADA2 c.882-2A>G Pathogenic ★★ same condition
- ADA2 c.973-2A>G Pathogenic ★★ same condition
- ADA2 p.Arg169Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada2-p-gly25ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown